14 results
424B7
HUMA
Humacyte Inc
4 Apr 22
Prospectus with selling stockholder info
5:22pm
to negotiate U.S. drug pricing to align with foreign drug pricing, pricing transparency measures, reform of drug rebate programs, and conditioning coverage … .” Additionally, there has been increasing legislative and enforcement interest in the United States with respect to specialty drug pricing practices
POS AM
HUMA
Humacyte Inc
30 Mar 22
Prospectus update (post-effective amendment)
5:07pm
and issued proposals regarding containment of drug prices through various means, including enabling CMS to negotiate U.S. drug pricing to align … with foreign drug pricing, pricing transparency measures, reform of drug rebate programs, and conditioning coverage and reimbursement of certain drugs upon
424B7
HUMA
Humacyte Inc
10 Dec 21
Prospectus with selling stockholder info
12:00am
to negotiate U.S. drug pricing to align with foreign drug pricing, pricing transparency measures, reform of drug rebate programs, and conditioning coverage … .” Additionally, there has been increasing legislative and enforcement interest in the United States with respect to specialty drug pricing practices. Specifically
POS AM
9o5fyci45o1u5 zky
19 Nov 21
Prospectus update (post-effective amendment)
5:26pm
424B7
4mb0ehq2gt511zx6
27 Oct 21
Prospectus with selling stockholder info
2:42pm
S-4/A
ugd7yo 2f
14 Jun 21
Registration of securities issued in business combination transactions (amended)
12:00am
S-4
d7q9l5inr254 vkw5vt
23 Mar 21
Registration of securities issued in business combination transactions
12:00am
- Prev
- 1
- Next